MADRIGAL PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 193.3 USD | -0.54% |
|
-8.82% | -16.44% |
Chart calendar Madrigal Pharmaceuticals, Inc.
c107ee8b86a1d66e2bf39daaf08b53e6.fyFwE1wdPIhqPXHypPz_ssxlP6avinTvLeKgOvicc5Y.JXQ9fDprDroJUyCYnJmt-Jw9apD1zkHYaI2YDKzrGc4ZDAAmBkdt6g8FPA~7a521ef17f9d12824e67c8ab5a7de895
Upcoming events on Madrigal Pharmaceuticals, Inc.
Past events on Madrigal Pharmaceuticals, Inc.
| 2024-03-14 05:15 pm | Rezdiffra™ (resmetirom) Accelerated Approval Call |
| 2024-02-28 07:00 am | Q4 2023 Earnings Release |
| 2024-01-10 07:30 pm | JPMorgan Healthcare Conference |
| 2024-01-03 | NASH TAG Conference - Abstract No:27 |
| 2024-01-03 | NASH TAG Conference - Abstract No:26 |
| 2024-01-03 | NASH TAG Conference - Abstract No:25 |
| 2024-01-03 | NASH TAG Conference - Abstract No:21 |
| 2024-01-03 | NASH TAG Conference - Abstract No:41 |
| 2023-11-30 01:00 pm | Piper Sandler Healthcare Conference |
| 2023-11-29 03:00 pm | Evercore ISI HealthCONx Conference |
| 2023-11-08 05:00 pm | UBS BioPharma Conference |
| 2023-11-06 08:00 am | Q3 2023 Earnings Release |
| 2023-08-08 08:00 am | Q2 2023 Earnings Release |
| 2023-06-24 12:30 pm | European Association for the Study of the Liver Congress |
| 2023-06-15 09:00 am | Annual General Meeting |
| 2023-06-13 12:20 pm | Goldman Sachs Global Healthcare Conference |
| 2023-06-07 02:30 pm | Jefferies Global Healthcare Conference |
| 2023-05-16 10:30 am | JMP Securities Life Sciences Conference |
| 2023-05-09 08:00 am | Q1 2023 Earnings Release |
| 2023-03-13 10:40 am | Oppenheimer Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 81,7 |
|
EBITDA Million USD | Released Forecast Spread | -94,9 -93,5 -1.44% | -206 -209 1.32% | -242 -244 0.7% | -293 -291 -0.77% | -380 -379 -0.29% | -570 |
|
EBIT Million USD | Released Forecast Spread | -95,0 -93,4 -1.66% | -207 -209 1.12% | -242 -244 0.66% | -294 -286 -2.59% | -380 -372 -2.42% | -496 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -83,9 -80,3 -4.57% | -202 -203 0.44% | -242 -242 0.26% | -295 -286 -3.35% | -374 -364 -2.75% | -462 |
|
Net income Million USD | Released Forecast Spread | -83,9 -80,3 -4.6% | -202 -203 0.44% | -242 -243 0.44% | -295 -287 -2.85% | -374 -365 -2.29% | -459 |
|
EPS USD | Released Forecast Spread | -5,45 -5,30 -2.74% | -13,1 -13,2 1.11% | -14,6 -14,7 0.21% | -17,2 -16,8 -2.69% | -20,0 -19,4 -2.78% | -23,3 |
| Announcement Date | 26/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 3,97 | 25,6 | 51,3 | 40,4 |
|
EBITDA Million USD | Released Forecast Spread | -78,2 -88,5 11.6% | -129 | -138 | -142 | -135 | |||||||||
|
EBIT Million USD | Released Forecast Spread | -64,6 -66,2 2.42% | -57,6 -60,6 4.98% | -70,3 -63,8 -10.22% | -80,4 -73,0 -10.17% | -85,3 -77,9 -9.49% | -78,3 -86,7 9.6% | -86,5 -84,7 -2.03% | -98,5 -92,9 -6.02% | -117 -108 -8.27% | -130 | -140 | -132 | -113 | -132 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -64,5 -65,2 1.01% | -57,5 -58,6 1.89% | -70,7 -65,3 -8.24% | -81,2 -71,3 -13.81% | -85,9 -76,6 -12.18% | -76,9 -87,8 12.46% | -85,8 -83,5 -2.71% | -98,7 -89,9 -9.86% | -112 -103 -8.51% | -125 | -136 | -123 | -101 | -110 |
|
Net income Million USD | Released Forecast Spread | -64,5 -65,6 1.67% | -57,5 -60,0 4.06% | -70,7 -64,1 -10.29% | -81,2 -72,6 -11.89% | -85,9 -77,9 -10.23% | -76,9 -86,7 11.32% | -85,8 -82,6 -3.94% | -98,7 -90,1 -9.64% | -112 -105 -7.1% | -123 | -132 | -121 | -102 | -110 |
|
EPS USD | Released Forecast Spread | -3,79 -3,86 1.8% | -3,36 -3,56 5.72% | -4,14 -3,68 -12.54% | -4,75 -4,14 -14.77% | -4,98 -4,50 -10.57% | -4,23 -4,99 15.15% | -4,69 -4,55 -3.12% | -5,34 -4,88 -9.4% | -5,68 -5,26 -7.88% | -6,20 | -6,54 | -6,10 | -5,13 | -6,25 |
| Announcement Date | 24/02/22 | 09/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 09/05/23 | 08/08/23 | 06/11/23 | 28/02/24 | - | - | - | - | - |
More events
Past sector events for Madrigal Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MDGL Stock
- Calendar Madrigal Pharmaceuticals, Inc.
